Skip to main content
. 2023 Apr 4;24(7):6725. doi: 10.3390/ijms24076725

Figure 1.

Figure 1

Summary of circulating TRAIL and TRAIL receptor levels in atherosclerotic vascular diseases including coronary artery disease (CAD), stroke, and peripheral artery disease (PAD); s, soluble; ↑, increased; ↓, decreased. Details are within the text.